Latest filing published 02 May 2022 for Neogenomics INC, €41k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William Bonello: trading record in brief
William Bonello is a declared insider of Neogenomics Inc (chief executive), with filings sourced from SEC (Form 4). The record holds 29 filings, for trades running from 26 February 2019 to 28 April 2022.
Every open-market trade on record is a sale: 7 sales worth €3.4M. Outside the open market, there are 11 share grants and 11 option exercises. Since January 2022: no purchases and 1 sale on the market.
The record was last updated on 2 May 2022 with an option exercise (€41k) in Neogenomics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Bonello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,727 shares@ US$7.529.3% of flowCommon StockSEC:0001077183-22-000071:0
- 82,305 shares0Common StockSEC:0001077183-22-000056:0
- 3,209 shares@ US$18.2912.3% of flowCommon StockSEC:0001077183-22-000049:0
- 40,869 shares0Common StockSEC:0001077183-22-000040:0
- 21,400 shares0Common StockSEC:0001077183-21-000275:0
- 25,000 shares@ US$7.5237.8% of flowCommon StockSEC:0001077183-21-000254:0
- 25,000 shares@ US$8.0340.6% of flowCommon StockSEC:0001077183-21-000251:0
7 of 7 declarations
